Welcome to our dedicated page for Usana Health Sciences news (Ticker: USNA), a resource for investors and traders seeking the latest updates and insights on Usana Health Sciences stock.
USANA Health Sciences, Inc. (NYSE: USNA) is a global nutrition company that develops and manufactures nutritional supplements, functional foods, personal care products, skincare, and healthy living products. This news page aggregates coverage of USANA’s announcements, giving readers a focused view of how the company communicates about its business, products, and strategic priorities.
Investors and observers can use this page to follow USANA’s updates on net sales outlooks, segment performance, and guidance, as reflected in press releases tied to events such as investor conferences and quarterly results. The company issues news on its direct selling operations, its Hiya direct-to-consumer segment, and its Rise Wellness business, including commentary on growth expectations, investments in inventory and capital expenditures, and integration initiatives.
USANA also publishes product-focused news, such as third-party certifications for its Probiotic and MagneCal D supplements, which have earned the ConsumerLab.com Seal of Approval. These items highlight the company’s emphasis on purity, potency, and scientific standards for its nutritional products. Additional stories cover partnerships, including its collaboration with the Jamaica Bobsleigh and Skeleton Federation, and community initiatives led by the USANA Foundation to address food insecurity.
Leadership and culture are recurring themes in USANA’s communications, with messages from its Executive Chairman and CEO on growth mindset, values-based leadership, and social wellness. By visiting this page regularly, readers can track how USANA presents its strategy, product quality, philanthropy, and international footprint through official news releases.
USANA (NYSE:USNA) announced on October 16, 2025 that its maximum-strength Vitamin D supplement earned the ConsumerLab.com Seal of Approval for potency, purity, and label accuracy.
The tablet delivers 50 mcg (2000 IU) vitamin D3 per dose and includes vitamin K; testing required 100% of claimed ingredient amounts plus proper disintegration and bioavailability. Company executives framed the certification as validation of USANA's manufacturing, third-party testing, and evidence-based product standards.
USANA (NYSE: USNA) reported preliminary Q3 2025 results: net sales $214 million versus $200 million a year ago. Operating earnings were approximately $1.2 million (0.6% of sales) versus $15.6 million in Q3 2024. Pretax earnings totaled $1.8 million but an $8.3 million income tax expense produced an unusually high 471% effective tax rate, driving a net loss of $6.5 million and diluted EPS of $(0.36). Adjusted diluted EPS was $(0.15) and Adjusted EBITDA was $13.8 million (vs. $24.6 million). Management cited softer Brand Partner productivity during a compensation-plan rollout and weaker Hiya DTC customer acquisition; Hiya is still expected to deliver double-digit sales growth in 2025. The company said full-year sales are likely at or near the low end of prior outlook and EPS will be below the prior range. Final results will be released Oct 21, 2025 and a call is scheduled Oct 22, 2025.
USANA (NYSE:USNA) announced that Chief Scientific Officer Dr. Kathryn Armstrong received the Women Tech Award — Leadership Excellence Award — from the Women Tech Council of Utah on Oct 6, 2025. The recognition highlights Dr. Armstrong's leadership in technology and scientific innovation and underscores USANA's emphasis on R&D, product quality, and support for women in the workplace. Dr. Armstrong leads a team of more than 150 scientific and quality professionals and joined USANA in 2024.
Her background includes a B.S. in Chemistry and a Ph.D. in Biochemistry; she credited the award to her USANA team and said it will motivate continued innovation.
USANA Health Sciences (NYSE: USNA) Executive Chairman Kevin Guest emphasizes the importance of service in strengthening leadership and emotional well-being during Emotional Wellness Month. Guest, author of "All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony", outlines six ways service enhances mental resilience.
The key benefits include disrupting negative thinking, restoring perspective, energizing the giver, rewiring emotional patterns, reaffirming identity, and strengthening relationships. Guest shares personal examples, including his father's dedication to serving Mr. Crum, a former business owner. All proceeds from the book support the USANA Foundation, which has provided over 112 million meals to impoverished families, with each book purchase contributing 40 meals.
USANA (NYSE: USNA) has unveiled the next generation of its Celavive skincare brand, featuring enhanced formulations and new products designed to work at the cellular level. The upgraded line includes the Vitalizing Serum with 4x more actives, new Bi-Phase Makeup Remover, Contouring Face & Neck Crème with Feminage™, Triple Action Eye Cream with 10x more active ingredients, and an improved Perfecting Toner.
The company has also announced partnerships with beauty experts Joy Tan and Violet Chan as global ambassadors to enhance brand education and engagement worldwide. The refreshed product line combines advanced scientific research with practical expertise to deliver visible skincare results.
USANA (NYSE:USNA) has announced significant enhancements to its Nutritionals product line, introducing new formulations and products. The company has upgraded its CellSentials supplement with PQQ for improved mitochondrial support, launched Core Aminos with HMB for muscle health, and introduced Circulate+ for cardiovascular support.
Additional products include an enhanced Proflavanol with expanded flavonoid content, Marine Collagen Peptides with 4.8g of marine collagen per serving, and an upcoming improved BiOmega supplement featuring better bioavailability. These innovations reflect USANA's commitment to advancing nutritional science and providing cutting-edge wellness solutions.
USANA Health Sciences (NYSE: USNA) Executive Chairman Kevin Guest is promoting self-improvement initiatives during September's Self-Improvement Month. Guest, author of "All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony," emphasizes the importance of personal growth in achieving success and fulfillment.
The initiative comes as the U.S. self-improvement industry reaches $12 billion annually. Guest shares three unique approaches to self-improvement: conducting a "Life Audit" with a trusted friend, creating a "Reverse Bucket List," and learning practical survival skills. The book's proceeds are dedicated to feeding hungry children, with each book purchase providing 40 meals.
USANA (NYSE:USNA), a global cellular nutrition company, unveiled significant product innovations and developments at its 2025 Global Convention. The company announced several new products, including Circulate+, Core Aminos, Marine Collagen Peptides, and multiple Celavive skincare products. Additionally, USANA introduced reformulated versions of popular products like BiOmega, CellSentials, and HealthPak.
A key highlight was the establishment of USANA's Health Professional Advisory Council, comprising industry experts who will serve as brand ambassadors and contribute to product development. The council aims to enhance product credibility and improve customer experiences while supporting USANA's vision for global health and wellness.
USANA Health Sciences (NYSE: USNA) Executive Chairman Kevin Guest has shared seven key daily habits for achieving lasting wellness during National Wellness Month. Guest, author of "All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony", emphasizes that wellness is achieved through consistent daily practices rather than dramatic lifestyle changes.
The seven habits include: starting with stillness, intentional nutrition, daily movement, positive self-talk, maintaining strong relationships, setting healthy boundaries, and practicing gratitude. The book's proceeds support hunger relief, with each purchase providing 40 meals to children in need.
USANA Health Sciences (NYSE:USNA) reported Q2 2025 results with net sales of $236 million, up 11% year-over-year, while net earnings decreased 7% to $9.7 million. The company's diluted EPS was $0.52, down from $0.54, though adjusted diluted EPS increased to $0.74.
The company's direct selling business saw Active Customers decline to 418,000, while Hiya, their direct-to-consumer segment, maintained 200,400 Active Monthly Subscribers. USANA reiterated its fiscal 2025 outlook, projecting consolidated net sales of $920 million to $1.0 billion.
Key developments include a new Disney partnership for Hiya's vitamin products, implementation of enhanced sales incentives, and adoption of 'Brand Partner' terminology. The company maintains a strong financial position with $151 million in cash and zero debt, while continuing share repurchases with $34 million remaining under current authorization.